EDIT:NASDAQ
Editas Medicine Inc
$2.78
arrow_downward
-0.36%(-0.0100) 1D
Okt 6, 10:25:20 AM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa EDIT...
Buksan
$2.85
Mataas
$2.90
Mababa
$2.76
Mkt. cap
400.94M
Avg. na dami
2.91M
Dami
793.60K
Mataas nang 52-wk
$4.54
Mababa nang 52-wk
$1.66
EPS
-$0.74
Beta
2.00
Mga natitirang share
153.58M
Bilang ng mga empleyado
87
Buksan
$2.85
Mataas
$2.90
Mababa
$2.76
Mkt. cap
400.94M
Avg. na dami
2.91M
Dami
793.60K
Mataas nang 52-wk
$4.54
Mababa nang 52-wk
$1.66
EPS
-$0.74
Beta
2.00
Mga natitirang share
153.58M
Bilang ng mga empleyado
87
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
AD HOC NEWS
·
4 oras ang nakalipas
Editas Medicine stock gains as Q2 revenue reaches USD 11.89 million
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
Tungkol sa Editas Medicine Inc